Anat Eldar‐Boock
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 5%
Papers in
-
- RNA Interference and Gene Delivery 4
- Angiogenesis and VEGF in Cancer 4
- Biomaterials 12
- Nanoparticle-Based Drug Delivery 11
- Co-authors
- Ronit Satchi‐Fainaro (32 shared papers)Anna Scomparin (7 shared papers)Dina Polyak (7 shared papers)Doron Shabat (3 shared papers)Galia Tiram (8 shared papers)Samer Gnaim (2 shared papers)Shiran Ferber (4 shared papers)Rachel Blau (3 shared papers)
- Journals
- Journal of Controlled Release (4 papers)Advanced Therapeutics (2 papers)Biomaterials (2 papers)Polymers for Advanced Technologies (2 papers)Cancer Research (2 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Anat Eldar‐Boock
35 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 107
- Biomaterials 543
- Molecular Medicine 81
- Biomedical Engineering 678
- Pharmaceutical Science 90
- Microbiology 88
Countries citing papers authored by Anat Eldar‐Boock
This map shows the geographic impact of Anat Eldar‐Boock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Eldar‐Boock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Eldar‐Boock more than expected).
Fields of papers citing papers by Anat Eldar‐Boock
This network shows the impact of papers produced by Anat Eldar‐Boock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Eldar‐Boock. The network helps show where Anat Eldar‐Boock may publish in the future.
Co-authors
The 25 scholars most cited alongside Anat Eldar‐Boock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 246 | |
| 2 | 2011 | 245 | |
| 3 | 2021 | 136 | |
| 4 | 2011 | 105 | |
| 5 | 2013 | 95 | |
| 6 | 2012 | 85 | |
| 7 | 2017 | 81 | |
| 8 | 2011 | 77 | |
| 9 | 2013 | 75 | |
| 10 | 2019 | 72 | |
| 11 | 2015 | 63 | |
| 12 | 2020 | 56 | |
| 13 | 2016 | 54 | |
| 14 | 2018 | 48 | |
| 15 | 2015 | 39 | |
| 16 | 2012 | 38 | |
| 17 | 2012 | 34 | |
| 18 | 2020 | 34 | |
| 19 | 2012 | 24 | |
| 20 | 2017 | 20 |
About Anat Eldar‐Boock
Anat Eldar‐Boock is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Oncology and Immunology and Allergy, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (9 papers), Bone health and treatments (5 papers), RNA Interference and Gene Delivery (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (4 papers), Cancer Cells and Metastasis (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Biomaterials (543 citations), Molecular Medicine (81 citations), Biomedical Engineering (678 citations), Pharmaceutical Science (90 citations) and Microbiology (88 citations). Anat Eldar‐Boock has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Ronit Satchi‐Fainaro, Anna Scomparin, Dina Polyak, Doron Shabat, Galia Tiram, Samer Gnaim, Shiran Ferber, Rachel Blau, Ori Green and Keren Miller. Their work appears in journals such as Journal of Controlled Release, Advanced Therapeutics, Biomaterials, Polymers for Advanced Technologies and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.